3Paniagua R,Amato D,Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial[].Journal of the American Society of Nephrology.2002
4Bethesda US.Department of health and human service,Public Health,National institutes of Health[].United States Renal Data System Report.1998
5MP Hrl,M Tepel.Drug therapy for hypertension in hemodialysis patients[].Minerva Medica.2005
6Zager PG, Nikolic J, Brown RH, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc[T]. Kidney Int, 1998,54: 561-569.
7Port FK, Hulbert-Shearon TE, Wolfe RA,, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients[J].AmJ Kidney Dis, 1999, 33:507-517.
8Heerspink HJ, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: A systematic review and meta-analysis of randomised controlled trials[J]. Lancet, 2009.373:1009-1015.
9Agarwal R, Sinha AD. Cardiovascular protection with anti- hypertensive drugs in dialysis patients: Systematic review and meta-analysis[J].Hypertension, 2009,53:860-866.
10Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients[J].J Am Soc Nephrol, 2006,17:513-520.
2Gluhovschi G, Velciov S, Petrica L, et al. Aspects of renal-pulmonary pathogenic replationships in chronic kidney disease and chronic pulmonary diseases a less- known connection[J]. Rom J Intern Med, 2014, 52(2): 68-77.
3Vethe H, Finne K, Skogstrand T, et al. Distinct protein signature of hypertension-induced damage in the renal proteome of the two-kidney, one-clip rat model[J]. J Hypertens, 2015, 33(1): 126-135.
4Muntner P, Davis BR, Cushman WC, et al. Treatment- resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TriaI(ALLHAT)[J]. Hypertension, 2014, 64(5): 1012-1021.
5Guessous I, McClellan W, Kleinbaum D, et al. Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study[J]. J Ren Nutr, 2014, 24(5): 303-312.
6Sim JJ, Shi J, Kovesdy CP, et al. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population[J]. J Am Coil Cardiol, 2014, 64(6): 588-597.
7Hassan M, Qureshi W, Sroujieh LS, et al. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease[J]. J Renin Angiotensin Aldosterone Syst, 2014, 15(3): 278-285.
